Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_assertion type Assertion NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_head.
- NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_assertion description "[We conclude that anti-CD19 chimeric receptors containing 4-1BB are a powerful new tool for T-cell therapy of B-lineage ALL and other CD19+ B-lymphoid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_provenance.
- NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_assertion evidence source_evidence_literature NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_provenance.
- NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_assertion SIO_000772 14961035 NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_provenance.
- NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_assertion wasDerivedFrom befree-20140225 NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_provenance.
- NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_assertion wasGeneratedBy ECO_0000203 NP626001.RAict0FjmA4NUJmyPQ8t2ODBAcrfDclWtWwdAqtqfEpsE130_provenance.